Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
DaveV-1's Profile
Displaying 1-50 of 51 result(s).
CYDY CytoDyn Inc
03/06/2021 1:08:05 AM
Info on PR is on Reddit and Open Sh (1)
CYDY CytoDyn Inc
01/30/2021 1:02:33 AM
Philippine video URL https://youtu.
CYDY CytoDyn Inc
01/27/2021 12:22:17 AM
Dr Patterson presentation at PMWC 2 (2)
CYDY CytoDyn Inc
01/25/2021 9:41:06 PM
An audio to fill the void and lift (6)
CYDY CytoDyn Inc
01/14/2021 3:36:48 PM
Interview with Dr. Janet Woodcock n
CYDY CytoDyn Inc
01/12/2021 4:41:20 PM
Today should be Day 28 or close to (3)
CYDY CytoDyn Inc
01/05/2021 12:33:05 PM
Post unblinding data collection, an (6)
CYDY CytoDyn Inc
12/28/2020 11:26:53 PM
MMH sale of stock acquired via opti (1)
CYDY CytoDyn Inc
12/15/2020 5:33:28 PM
Realistic Expectation for CD12 P3 T (1)
CYDY CytoDyn Inc
12/04/2020 8:47:21 PM
Philippines President Duterte: Exec
CYDY CytoDyn Inc
11/13/2020 8:35:36 PM
Another therapeutic treating Severe (2)
CYDY CytoDyn Inc
11/13/2020 12:54:03 AM
Dr. Janet Woodcock NEJM interview: (3)
CYDY CytoDyn Inc
10/23/2020 3:09:05 PM
EUA Approval Urgency Good possibili
CYDY CytoDyn Inc
10/03/2020 8:40:16 PM
CYDY interest in searches up a bit (1)
CYDY CytoDyn Inc
09/24/2020 6:14:48 PM
corrected URL to Prnewswire for Inc
CYDY CytoDyn Inc
09/23/2020 8:22:22 PM
Melon Toy update This was posted by (4)
CYDY CytoDyn Inc
09/20/2020 1:01:15 AM
CD12 data collection Data collectio (1)
CYDY CytoDyn Inc
09/11/2020 1:23:45 AM
Fatigue waiting for "blast-off" Loo (1)
CYDY CytoDyn Inc
09/11/2020 1:19:59 AM
PDUFA Date for HIV review for appro (2)
CYDY CytoDyn Inc
09/09/2020 5:32:02 PM
Leronlimab vials manufactured by Sa (2)
CYDY CytoDyn Inc
09/08/2020 12:48:49 AM
Priority of Alzheimer's Trial Submi (2)
CYDY CytoDyn Inc
09/03/2020 8:57:18 PM
Samsung Biologics to add a fourth p
CYDY CytoDyn Inc
09/03/2020 8:47:46 PM
CCR5 expression in cancer This was (1)
CYDY CytoDyn Inc
09/02/2020 8:33:52 PM
Replacing the need for biopsies is
CYDY CytoDyn Inc
08/30/2020 9:14:29 PM
Creatv partnered with CYDY to use L (8)
CYDY CytoDyn Inc
08/21/2020 9:07:14 PM
RLFTF Cov19 opportunity and investm (1)
CYDY CytoDyn Inc
08/20/2020 1:13:57 PM
Info & Enrollment in Clinical Trial (1)
CYDY CytoDyn Inc
08/19/2020 10:19:26 AM
NY Times, Blood Plasma Emergency Ap (1)
CYDY CytoDyn Inc
08/18/2020 9:29:39 PM
Levels of Rantes or CCR5? I believe (1)
CYDY CytoDyn Inc
08/18/2020 9:23:31 PM
Two thoughts: I expect some change (1)
CYDY CytoDyn Inc
08/18/2020 1:56:48 AM
Reality Check - timeline of EUA gra
CYDY CytoDyn Inc
08/14/2020 6:38:05 PM
Interview supporting a key element (1)
CYDY CytoDyn Inc
08/06/2020 10:03:48 AM
Decreasing Trend % of "Short" Tradi
CYDY CytoDyn Inc
07/30/2020 5:14:24 PM
No date for the meeting, just that
CYDY CytoDyn Inc
07/29/2020 3:48:03 PM
Dr Patterson comments on cytokines
CYDY CytoDyn Inc
07/22/2020 8:22:21 PM
The shareholder call July 22 replay
CYDY CytoDyn Inc
07/21/2020 11:04:32 AM
Lets Get Real: My thought "patience (10)
CYDY CytoDyn Inc
07/20/2020 11:32:27 AM
RE: CCR5 receptor occupancy test an (1)
CYDY CytoDyn Inc
07/18/2020 10:11:32 PM
IncellDX and LabConnect The decisio (4)
CYDY CytoDyn Inc
07/13/2020 7:38:36 AM
BLA RTF Impact on Share Price Not s (1)
CYDY CytoDyn Inc
07/10/2020 5:05:01 PM
Only point I have in my notes was f
CYDY CytoDyn Inc
07/10/2020 11:59:47 AM
Dr Patterson's CCL5/Rantes Paper La (1)
CYDY CytoDyn Inc
07/10/2020 10:33:46 AM
Voting the Proxy - voting deadline (1)
CYDY CytoDyn Inc
07/09/2020 8:41:50 PM
FDA BLA review process and signific (3)
CYDY CytoDyn Inc
07/09/2020 3:46:15 PM
Phase 2b/3 interim analysis and "ad (2)
CYDY CytoDyn Inc
07/08/2020 8:07:27 PM
SEC filing for distribution for Cov (1)
CYDY CytoDyn Inc
07/08/2020 7:55:29 PM
Possible FDA response on BLA for HI
CYDY CytoDyn Inc
07/08/2020 7:50:15 PM
Cytodyn filed with SEC the distribu
CYDY CytoDyn Inc
07/06/2020 7:32:48 AM
TedX Bill Gates on monoclonal antib (2)
CYDY CytoDyn Inc
07/01/2020 4:17:57 PM
MM CD10 trial 14 day treatment wind (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding iOThree Limited's Compliance Notification from Nasdaq
  • Captivision, Inc. Faces Nasdaq Compliance Challenges Ahead
  • The Children’s Place Reflects on First Quarter 2025 Outcomes
  • Marimaca Copper Corp. Delivers Positive AGM Voting Results
  • Fulcrum Therapeutics Announces New Employee Stock Options Grant
  • ORIC Pharmaceuticals' New Employee Incentive Programs Explained
  • Talisker Resources Secures $14 Million Private Placement Funds
  • Zealand Pharma Expands Capital Through Employee Warrant Exercise
  • Understanding Northann Corp's Response to Stock Market Fluctuations
  • Arcutis Biotherapeutics Awards Restricted Stock Units to New Hires
  • Magnetic North's Recent Updates on Management Trading Status
  • Broadway Technology Merges with Quartzsea Acquisition Corp
  • Playa Hotels & Resorts Confirms Antitrust Approval Ahead of Sale
  • Genpact Limited Announces Quarterly Cash Dividend Increase
  • DICK'S Sporting Goods Initiates Exchange Offer for Foot Locker Debt
  • Replimune's Innovative Employee Inducement Strategy
  • Keros Therapeutics to Showcase Innovations at Health Conference
  • Enovis Corporation to Showcase Innovations at Investor Events
  • Breaking Down TELA Bio's New Stock Options for Leadership Team
  • PolyPid's Upcoming Call on D-PLEX100 Trial Results and Insights
  • Globalink Investment Extends Business Combination Deadline Effectively
  • 89bio Approves New Stock Options Grant for Employees
  • Rakovina Therapeutics Secures $4.9 Million Through Private Placement
  • SRQ Resources Inc. Reports Successful Shareholder Meeting Results
  • Opendoor's Proxy Filing: Revolutionizing Real Estate with Confidence
  • Investors Urged to Join Ibotta, Inc. Class Action Lawsuit
  • Leading NAPCO Security Technologies Class Action Opportunities
  • Kennametal Completes Strategic Sale of Subsidiary, Boosting Growth
  • Spyre Therapeutics Grants Stock Options to Boost Team Growth
  • Kojamo Announces Sale of 44 Residential Properties for EUR 242M
  • Strategic Leadership Shift: Matt Mayfield as CEO of Camwood
  • SKEL Transaction Enhances Strategic Shareholder Base in Styrkás
  • Treace Medical Concepts Class Action: A Chance for Investors
  • Marsai Martin and Seeds of Fortune Unite to Empower Women
  • Revolutionizing Safety and Nutrition with Wild About Sprouts
  • Essential Insights on BigBear.ai Holdings Investors' Rights
  • Teamsters Expanded Strike at Sutphen Corporation Headquarters
  • Review of Silvano Fashion Group's 2024 Annual Financial Report
  • Synthetic Grass Warehouse Expands with a New Atlanta Facility
  • Ally Walker's 'The Light Runner' Challenges Perception in Fiction
  • Dionisio Gutiérrez Honored with Prestigious Award by Spain's King
  • Investors in Zenas BioPharma Urged to Join Class Action Lawsuit
  • Celebrating the Historic Reopening of Dianetics Landmark Site
  • PG&E's Vision for a Safer Future: Wildfire Preparedness Insights
  • Revolutionizing Church Interactions with Subsplash Tap Technology
  • Kwanza Jones Celebrates Teyana Taylor with Innovator Award
  • Dionisio Gutiérrez Honored with Prestigious Award by Spain
  • StarKist and Feed the Children Host Food Resource Event
  • La Bronca Joins reVolver Podcasts to Empower Communities
  • Innovative Study Revolutionizes Colorectal Cancer Treatment Options
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site